Volume 8, Number 10—October 2002
Epidemiologic Investigations of Bioterrorism-Related Anthrax, New Jersey, 2001
||No. of cases with clinical finding
|Edema surrounding skin lesion||4/4|
|Lesion associated with pustules or vesicles||2/4|
|Blood culture positive for Bacillus anthracis||1/4b|
|Blood or tissue positive for B. anthracis by PCR||2/4|
|IHC staining positive for B. anthracis||3/4c|
|Convalescent-phase serumd: anti-PA IgG antibodies present (“reactive serology”)||4/4|
aIHC, immunohistochemical staining; PCR, polymerase chain reaction; anti-PA IgG, anti-protective antigen immunoglobulin G.
bOnly 1/4 patients with cutaneous anthrax had blood cultures drawn before the initiation of antibiotic therapy. This was the one patient with a blood culture positive for B. anthracis.
cThe 4th patient did not have tissue available for IHC staining.
dConvalescent-phase serum is serum drawn at least 14 days after symptoms begin.
1 The CDC New Jersey Anthrax Investigation Team consists of Paul P. Abamonte, Chidinma Alozie-Arole, Gregory Armstrong, Sherrie Bruce, Shadi Chamany, Diane Crawford, Donita R. Croft, Colleen Crowe, Stephanie I. Davis, George DiFerdinando, Catherine Dentinger, Deborah A. Deppe, Mary Dillon, Mary Dott, Leigh A. Farrington, Michael Fraser, Dara S. Friedman, Jessica Gardom, Carol Genese, Dawn Gnesda, Rita Helfand, Beth C. Imhoff, Greg J. Jones, Renee Joskow, Pavani Kalluri, Sean G. Kaufman, Melody Kawamoto, Malinda Kennedy, Jonathon D. King, Susan McClure, Michelle McConnell, Peter D. McElroy, Kenneth R. Mead, Suzanne Miro, R. Leroy Mickelsen, Jeff Nemhauser, Mita Patel, Cindi Pecoraro, Marion Pierce, Lisa Roth-Edwards, Hardeep Sandhu, Donald Schill, Michael Sells, Nicole Tucker, Reuben Varghese, Daniel J. Yereb, and Juan Zubieta.
- Page created: July 19, 2010
- Page last updated: July 19, 2010
- Page last reviewed: July 19, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)